跳至主要内容
临床试验/NCT04426565
NCT04426565Unknown不适用

The 9-month Follow-up Study for the Patients of Illicit Substance Use Disorder After Receiving the Different Psychosocial Intervention

Kaohsiung Kai-Suan Psychiatric Hospital2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
2
主要终点
The severity of substance use used by the Severity of Dependence Scale

研究概览

简要总结

The patients will be diagnosed according to DSM-5, the severity of individual substance use disorder will be assessed, and the plan of treatment will be provided. The treatment will be determined by the diagnosis and severity of addiction, the mood or psychiatric comorbidities, the hyperactivity or attention deficit, alcohol addiction, and etc. The motivational enhancement interview, the individual psychotherapy, the group psychotherapy, the family therapy will be provided by our team members. In order to evaluate the efficacy of the different therapy, we will evaluate the psychological and social status of the patients and follow up every 3 months. The efficacy of different treatment will be evaluated according to our study instruments.

详细描述

The patients will be diagnosed according to DSM-5, the severity of individual addiction will be assessed, and the plan of treatment will be provided. The treatment will be determined by the diagnosis and severity of addiction, the mood or psychiatric comorbidities, the hyperactivity or attention deficit, alcohol addiction, and etc. The motivational enhancement interview, the individual psychotherapy, the group psychotherapy, the family therapy will be provided by our team members. In order to evaluate the efficacy of the different therapy, we will evaluate the psychological and social status of the patients and follow up every 3 months.

The patients will be received the basic physiological assessment, the chest X-ray, electrocardiogram, liver and renal function, hematology test, urine screening for addictive substances, screening for blood infectious diseases (including hepatitis B, C and HIV infection) will be included.

Besides, the Drug Abuse Screen Test (DAST), the Severity of Dependence Scale (SDS), the Reliability of Readiness to Change Questionnaire, the Opiate Treatment Index (OTI), drug Avoidance Self-Efficacy Scale (DASES), the Family APGAR score, The brief version of the World Health Organization Quality of Life instrument (WHOQOL-BREF Taiwan version), Chinese health questionnaire (CHQ), parental bonding instrument (PBI), Toronto Alexithymia Scale (TAS), Brief Symptom Rating Scale (BSRS-5), Chinese version of Adult ADHD Self-Report Scale (ASRS-V1. 1), Becker Depression Scale (BDI) and Becker Anxiety Scale (BAI) will be evaluated every 3 months after receiving our treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with illicit substance use disorder diagnosed by DSM-5

排除标准

  • The age of the patient is below 20 years old or above 65 years old, the patients cannot cooperate with the tools of investigation

结局指标

主要结局

The severity of substance use used by the Severity of Dependence Scale

时间窗: 9 months

The value is from 0 to 15, and higher scores mean a worse outcome.

The World Health Organization Quality of Life instrument (WHOQOL-BREF Taiwan version)

时间窗: 9 months

The instrument has four dimension and higher scores mean a better outcome.

Becker Depression Scale

时间窗: 9 months

The value is from 0 to 63, and higher scores mean a worse outcome.

Becker Anxiety Scale

时间窗: 9 months

The value is from 0 to 63, and higher scores mean a worse outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验